SNN · Smith & Nephew PLC · Metrics
Market Cap
$11.26B
Shares
418.52M
Volume · Oct 6
407.74K
Avg daily vol (3M)
1.64M
SNN metrics
66 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$26.92
Market cap
$11.26B
Price action
20 metricsPrice change (1W)
-1.8%
Price change (30D)
-5.2%
Price change (3M)
-12.7%
Price change (6M)
-17.8%
Price change (YTD)
-19.5%
Price change (1Y)
-27.5%
Trailing year
Price change (5Y)
-24.9%
52-week high
$37.17
52-week low
$26.42
Change from 52-week high
-28.9%
Change from 52-week low
+0.0%
Annualized volatility
27.9%
Annualized volatility (3M)
26.9%
Beta
0.4
RSI (14D)
30.5
Price vs SMA 50
-8.9%
Price vs SMA 200
-16.1%
Avg volume (3M)
1.64M
Relative volume
0.8
Average dollar volume
$48.33M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
418.52M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 55.9%
P / book
2.2
reciprocal yield 46.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
8.4
reciprocal yield 11.9%
Earnings yield
5.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
52.4%
Shareholder yield
3.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-04
Profitability
9 metricsGross margin
68.2%
Operating margin
12.9%
Trailing 12 months
Net margin
10.1%
Gross profit (TTM)
$4.30B
Operating profit (TTM)
$813.00M
Net income (TTM)
$635.00M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
20.3%
Growth
11 metricsRevenue growth YoY
+6.1%
Year over year
Net income growth YoY
+51.7%
Revenue (TTM)
$6.30B
Trailing 12 months
EPS growth YoY
+52.3%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
+5.7%
Revenue CAGR (5Y)
+6.2%
EPS CAGR (3Y)
+41.1%
EPS CAGR (5Y)
+6.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
12.3%
Return on assets
5.8%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$754.00M
Total assets
$11.01B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.34B
Capital expenditures (TTM)
—
R&D (TTM)
$303.00M
SG&A (TTM)
—
Stock compensation (TTM)
$56.00M
R&D / revenue
4.8%
Stock compensation / revenue
0.9%
Ownership (13F)
3 metrics13F filers
295
13F filer change QoQ
+15
Institutional ownership
8.7%
Short interest
3 metricsShort interest
1.2%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
48 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—